Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 29, 2018
Albireo to Present at Jefferies 2018 Global Healthcare Conference
BOSTON, May 29, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
May 29, 2018
UroGen Pharma to Present at the Jefferies 2018 Global Healthcare Conference
RA’ANANA, Israel and NEW YORK, May 29, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
May 29, 2018
Opiant Pharmaceuticals to Participate in The American Society of Clinical Psychopharmacology 2018 Annual Meeting
SANTA MONICA, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced ...
May 29, 2018
FDA Clears Development Pathway for NexoBrid® for Sulfur Mustard Injuries
YAVNE, Israel, May 29, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn ...
May 29, 2018
Spring Bank to Present at Jefferies 2018 Global Healthcare Conference
HOPKINTON, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
May 29, 2018
Arcturus Therapeutics Appoints Four New Directors and Reaches Settlement Agreement with Founder Joseph E. Payne
SAN DIEGO, May 29, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (ARCT) (“Arcturus” or the “Company), a leading RNA medicines company, today announced that, as ...
May 24, 2018
Prothena Announces Reorganization to Focus Resources on Advancing Neuroscience Pipeline
DUBLIN, Ireland, May 24, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (PRTA), a clinical-stage biotechnology company focused on the discovery and development of novel therapies ...
May 24, 2018
Eiger BioPharmaceuticals Prices Previously Announced Public Offering of Common Stock
PALO ALTO, Calif., May 24, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), a clinical-stage biopharmaceutical company focused on bringing to market novel product candidates for ...
May 24, 2018
BioTime Further Expands OpRegen® Clinical Trial in Dry-AMD With the Opening of Two Additional U.S. Sites
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced the expansion of its ongoing Phase I/IIa clinical ...
May 24, 2018
VBL Therapeutics to Present at Upcoming Conferences in June
TEL AVIV, Israel, May 24, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class ...
May 24, 2018
U.S. FDA Grants Fast Track Designation for Krystal Biotech’s KB103 for the Treatment of Dystrophic Epidermolysis Bullosa
PITTSBURGH, May 24, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal”) (KRYS), a gene therapy company developing topical and intradermal "off-the-shelf" treatments for rare dermatological ...
May 24, 2018
Achaogen Announces Multiple Plazomicin Presentations at ASM Microbe 2018 Annual Meeting
SOUTH SAN FRANCISCO, Calif., May 24, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative ...
May 23, 2018
BioDelivery Sciences to Present at the Jefferies 2018 Global Healthcare Conference
RALEIGH, N.C., May 23, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc., (BDSI), a specialty pharmaceutical company with a focus in pain management and addiction ...
May 23, 2018
PolarityTE Announces Howard Hechler from Smith & Nephew as the New Chief Business Officer
SALT LAKE CITY, May 23, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (COOL) today announced the appointment of Howard Hechler as Chief Business Officer. Mr. Hechler ...
May 23, 2018
Zosano Announces Publication of Most Bothersome Symptom Data from the ZOTRIP Pivotal Study in Headache: The Journal of Head and Face Pain
FREMONT, Calif., May 23, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company focused on providing rapid systemic ...
May 23, 2018
AIT Therapeutics Presented Data from Its Inhaled Nitric Oxide Study in Patients Infected with Mycobacterium Abscessus Complex (MABSC) at the 2018 American Thoracic Society Conference
NEW YORK, May 23, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide ...
May 23, 2018
Pfenex Announces Pricing of Offering of 6,800,000 Shares of Common Stock
SAN DIEGO, May 23, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American:PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression ...
May 23, 2018
Onxeo to Present at BIO International Convention in Boston
PARIS--(BUSINESS WIRE)--Regulatory News: Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO FR0010095596), a biotechnology company specializing in the development of innovative drugs in oncology, notably against rare ...
May 23, 2018
Transgene: Combined General Meeting of May 23, 2018
STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene’s (TNG.PA) shareholders held their Combined General Meeting (ordinary and extraordinary) today, chaired by Philippe Archinard, Chairman and CEO, to approve the ...
May 23, 2018
TherapeuticsMD Comments on Media Reports Regarding TX-004HR
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (TXMD), an innovative women’s healthcare company, today commented on media reports that TX-004HR, the company’s investigational applicator-free estradiol vaginal softgel ...
Page 38 of 117